ACE inhibitors and angiotensin receptor antagonists and the incidence of new-onset diabetes mellitus: an emerging theme
D Aguilar, SD Solomon - Drugs, 2006 - Springer
The prevalence of type 2 diabetes mellitus continues to rise. Given the associated co-
morbidities of obesity, hypertension and cardiovascular disease, the rising incidence of …
morbidities of obesity, hypertension and cardiovascular disease, the rising incidence of …
Neurohormones and heart failure: the importance of aldosterone
K Odedra, A Ferro - International journal of clinical practice, 2006 - Wiley Online Library
Heart failure is a major cause of cardiovascular morbidity and mortality and its incidence is
on the increase. The pathophysiology of heart failure is multi‐factorial but recent studies …
on the increase. The pathophysiology of heart failure is multi‐factorial but recent studies …
The implications of a growing evidence base for drug use in elderly patients Part 2− ACE inhibitors and angiotensin receptor blockers in heart failure and high …
AA Mangoni, SHD Jackson - British journal of clinical …, 2006 - Wiley Online Library
Traditionally, angiotensin converting enzyme (ACE) inhibitors have been used for the
management of patients with congestive cardiac failure. Studies performed over the last …
management of patients with congestive cardiac failure. Studies performed over the last …
Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure
PA Howard, JWM Cheng, MA Crouch… - Annals of …, 2006 - journals.sagepub.com
Objective: To review and discuss key aspects of the drug therapy recommendations in the
American College of Cardiology (ACC)/American Heart Association (AHA) 2005 Guideline …
American College of Cardiology (ACC)/American Heart Association (AHA) 2005 Guideline …
Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence
BR Dulin, H Krum - Current opinion in cardiology, 2006 - journals.lww.com
Agents that provide substantive clinical benefit overall also appear to do so in the elderly,
based on subgroup analysis of major trials. There have been very few prospective, placebo …
based on subgroup analysis of major trials. There have been very few prospective, placebo …
Angiotensin II receptor blockers in congestive heart failure
MJ Eisenberg, LC Gioia - Cardiology in Review, 2006 - journals.lww.com
The benefits of angiotensin-converting enzyme (ACE) inhibitors for the treatment of
congestive heart failure (CHF) are well-established. A newer class of medications …
congestive heart failure (CHF) are well-established. A newer class of medications …
Difficulties in maintaining potassium homeostasis in patients with heart failure
I Dursun, M Sahin - … Indexed and Peer‐Reviewed Journal for …, 2006 - Wiley Online Library
Potassium (K) concentration plays a significant role in cell metabolism and membrane
excitability. The imbalance of serum potassium is important because it can lead to life …
excitability. The imbalance of serum potassium is important because it can lead to life …
Angiotensin II antagonists–therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy
A Beltrame Ribeiro - Current medical research and opinion, 2006 - Taylor & Francis
Background: The cardiovascular benefits of angiotensin II antagonists (AIIAs) have been
evaluated not only in terms of their ability to lower blood pressure but also on their ability to …
evaluated not only in terms of their ability to lower blood pressure but also on their ability to …